CIK 0001042418 · Non-accelerated filer<br>Smaller reporting company
Inhibitor Therapeutics, Inc.
Sign in to watch- Ticker
- INTI
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 541641133
- Phone
- (813) 766-2462
- Business address
- 4830 W. KENNEDY BLVD., SUITE 600, TAMPA, FL, 33609
- Former names
- HedgePath Pharmaceuticals, Inc., COMMONWEALTH BIOTECHNOLOGIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 78 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-11-15 | Mayne Pharma Ventures Pty Ltd 10% owner | Option exercise | +333 | 192,646,132 | ||
| 2016-11-15 | Mayne Pharma Ventures Pty Ltd 10% owner | Option exercise | +4,860,000 | 197,506,132 | ||
| 2016-11-15 | Mayne Pharma Ventures Pty Ltd 10% owner | Option exercise · Warrant to Purchase Common Stock | −4,750,569 | 0 | ||
| 2016-11-15 | Mayne Pharma Ventures Pty Ltd 10% owner | Option exercise · Warrant to Purchase Common Stock | −333 | 0 | ||
| 2016-11-15 | Mayne Pharma Ventures Pty Ltd 10% owner | Option exercise · Warrant to Purchase Common Stock | −4,860,000 | 23,504,236 | ||
| 2016-11-04 | Mayne Pharma Ventures Pty Ltd 10% owner | Option exercise | +5,500,000 | 154,562,230 | ||
| 2016-11-04 | Mayne Pharma Ventures Pty Ltd 10% owner | Option exercise | +33,333,000 | 187,895,230 | ||
| 2016-11-04 | Mayne Pharma Ventures Pty Ltd 10% owner | Option exercise · Warrant to Purchase Common Stock | −5,500,000 | 4,750,569 | ||
| 2016-11-04 | Mayne Pharma Ventures Pty Ltd 10% owner | Option exercise · Warrant to Purchase Common Stock | −33,333,000 | 333 | ||
| 2016-07-01 | Watson W. Mark Director | Grant or award · Restricted Stock Units | +200,000 | 200,000 | ||
| 2016-07-01 | Watson W. Mark Director | Grant or award · Options to Purchase Common Stock | +200,000 | 200,000 | ||
| 2016-07-01 | SEARS SAMUEL P JR Director | Grant or award · Restricted Stock Units | +150,000 | 150,000 | ||
| 2016-07-01 | SEARS SAMUEL P JR Director | Grant or award · Options to Purchase Common Stock | +150,000 | 150,000 | ||
| 2016-07-01 | Ono Richard Dana Director | Grant or award · Restricted Stock Units | +150,000 | 150,000 | ||
| 2016-07-01 | Ono Richard Dana Director | Grant or award · Options to Purchase Common Stock | +150,000 | 150,000 | ||
| 2016-06-15 | HedgePath, LLC 10% owner | Sale | −2,560,000 | 82,127,069 | ||
| 2016-06-15 | ODONNELL FRANCIS E JR Executive Chairman | Purchase | +2,560,000 | 16,560,000 | ||
| 2016-06-15 | ODONNELL FRANCIS E JR Executive Chairman | Sale | −2,560,000 | 11,440,000 | ||
| 2016-06-06 | ODONNELL FRANCIS E JR Executive Chairman | Other disposition | −6,000,000 | 14,000,000 | ||
| 2016-05-25 | Mayne Pharma Group Ltd 10% owner | Grant or award | +27,885,000 | 149,062,230 |
Page 6 of 9 · 165 trades